Last reviewed · How we verify

NCT01778517

Treatment of Functional Movement Disorders With Psychotherapy

Completed NA Last updated 2 July 2017
What this trial tests

NA trial testing Group Psychotherapy in Movement Disorders in 9 participants. Completed in 23 July 2015.

Timeline
11 December 2012
Primary endpoint
23 July 2015
23 July 2015

Quick facts

Lead sponsorNational Institute of Neurological Disorders and Stroke (NINDS)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment9
Start date11 December 2012
Primary completion23 July 2015
Estimated completion23 July 2015
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Who can join

Adults 18 to 85, any sex, with Movement Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: \- Functional movement disorder (FMD) is a form of conversion disorder (CD). CD is a disorder in which a person has neurological symptoms that do not have a neurological cause. These symptoms can include pain, weakness, dizziness, and fatigue. Some thoughts on CD suggest that it may come from feelings of anxiety that are converted into physical symptoms. Treatment for FMD usually involves stress reduction, family help, and regular doctor s appointments. Therapy interventions, however, have not been well studied. Researchers want to see if people with FMD get better with psychotherapy. They will study two different types of psychotherapy: group therapy and a self-help manual. Objectives: \- To test two different types of therapy treatments for FMD. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with FMD by a neurologist. Design: * Participants will be screened with a physical exam and medical history. They will also have a psychological exam, and answer questions about their mood and symptoms. * Participants will be separated into three groups. One group will have group therapy. Another will use a self-help workbook designed for people with FMD, and have individual therapy sessions. A third group will just have standard care. During the study, participants will continue to see their regular doctor. * Group therapy participants will meet once a week for 6 months at the National Institutes of Health clinical center. There will be 8 to 10 people per group. Sessions will last 75 minutes. These sessions will work on methods for treating FMD. * Self-help workbook participants will have six individual therapy sessions over 3 to 4 months. They will use the workbooks to learn about and practice methods for treating FMD. * All participants will be evaluated at 3, 6, and 12 months during the study. * At the end of the study, participants will have a final follow-up session with exams and questions similar to the screening exam. They will return to the care of their regular doctor.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Psychosocial interventions for conversion and dissociative disorders in adults.
    Ganslev CA, Storebø OJ, Callesen HE, Ruddy R, et al · · 2020 · cited 14× · PMID 32681745 · DOI 10.1002/14651858.cd005331.pub3

Verify or expand the search:

Other trials of Group Psychotherapy

Trials testing the same drug.

Other recruiting trials for Movement Disorders

Currently open trials in the same condition.

Other National Institute of Neurological Disorders and Stroke (NINDS) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01778517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing